157 related articles for article (PubMed ID: 38457113)
41. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
[TBL] [Abstract][Full Text] [Related]
42. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
Wasag B; Lierman E; Meeus P; Cools J; Vandenberghe P
Haematologica; 2011 Jun; 96(6):922-6. PubMed ID: 21330321
[TBL] [Abstract][Full Text] [Related]
43. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ
Oncotarget; 2022; 13():659-676. PubMed ID: 35574218
[TBL] [Abstract][Full Text] [Related]
44. [The 8p11 myeloproliferative syndrome].
Reither A; Hehlmann R; Goldman JM; Cross NC
Med Klin (Munich); 1999 Apr; 94(4):207-10. PubMed ID: 10373756
[TBL] [Abstract][Full Text] [Related]
45. [Clinical Significance of FGFR1 Gene Abnormalities in Blood Tumors].
Zhang CL; Tang GS; Guo MQ; Cheng H; Liu MD; Yang JM; Gong SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):983-988. PubMed ID: 32552969
[TBL] [Abstract][Full Text] [Related]
46. Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11).
Wang T; Wang Z; Zhang L; Wen L; Cai W; Yang X; Pan J; Ruan C; Wu D; Sun A; Chen S
Br J Haematol; 2020 Jan; 188(1):177-181. PubMed ID: 31802477
[No Abstract] [Full Text] [Related]
47. The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion.
Onozawa M; Ohmura K; Ibata M; Iwasaki J; Okada K; Kasahara I; Yamaguchi K; Kubota K; Fujisawa S; Shigematsu A; Endo T; Kondo T; Hashino S; Tanaka J; Matsuno Y; Asaka M; Imamura M
Eur J Haematol; 2011 Apr; 86(4):347-9. PubMed ID: 21198859
[No Abstract] [Full Text] [Related]
48. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
[TBL] [Abstract][Full Text] [Related]
49. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
[TBL] [Abstract][Full Text] [Related]
50. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
[TBL] [Abstract][Full Text] [Related]
51. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review.
Macdonald D; Aguiar RC; Mason PJ; Goldman JM; Cross NC
Leukemia; 1995 Oct; 9(10):1628-30. PubMed ID: 7564500
[TBL] [Abstract][Full Text] [Related]
52. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and
Wehrli M; Oppliger Leibundgut E; Gattiker HH; Manz MG; Müller AM; Goede JS
Oncologist; 2017 Apr; 22(4):480-483. PubMed ID: 28242791
[TBL] [Abstract][Full Text] [Related]
53. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
[TBL] [Abstract][Full Text] [Related]
54. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
Duckworth CB; Zhang L; Li S
Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
[TBL] [Abstract][Full Text] [Related]
55. Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy chain gene rearrangement.
Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Mushino T; Kuriyama K; Tamura S; Hatanaka K; Hanaoka N; Nakakuma H
Acta Haematol; 2013; 129(4):238-42. PubMed ID: 23328683
[TBL] [Abstract][Full Text] [Related]
56. Myeloid/lymphoid neoplasm with a novel cryptic
Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
[No Abstract] [Full Text] [Related]
57. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with
Freyer CW; Hughes ME; Carulli A; Bagg A; Hexner E
Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350
[TBL] [Abstract][Full Text] [Related]
58. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
[No Abstract] [Full Text] [Related]
59. miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the
Hu T; Chong Y; Lu S; Wang R; Qin H; Silva J; Kitamura E; Chang CS; Hawthorn L; Cowell JK
Cancer Res; 2018 Jul; 78(13):3522-3531. PubMed ID: 29735550
[TBL] [Abstract][Full Text] [Related]
60. 11q23 abnormalities in adult Chinese patients with hematological malignancies.
Zhao X; Li S; Li N; Fan R; Lin G; Wang X
Med Oncol; 2014 Aug; 31(8):115. PubMed ID: 25008067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]